Genomic Efficacy Alerting System for Personalized Treatment

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current healthcare systems lack the ability to effectively integrate genetic information for determining medication efficacy, leading to inefficient treatment options and potential side effects due to individual genetic variations, and often fail to provide a streamlined process for genomic efficacy testing.

Innovation Solution

A system and method that utilizes genetic data to identify effective and ineffective treatment options by sequencing genetic material for specific markers, integrating the results into existing electronic medical record systems and healthcare provider networks to alert healthcare providers of potential issues and suggest alternative treatments.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If traditional historical effectiveness-based treatment prescription is used, then treatment options can be prescribed based on general population data, but individual genetic variations cause ineffective treatments, side effects, and resource wastage

Engineering Contradiction:
Improvetreatment effectivenessVSAvoidresource wastage
Core Design Contradiction:
ReliabilityVSLoss of energy

Solution Approach 1:

The system performs preliminary genetic testing before prescription to determine individual treatment response. Genetic markers are analyzed in advance to predict medication efficacy, allowing clinicians to select appropriate treatments before administering them, thereby avoiding ineffective prescriptions and reducing resource wastage from failed treatments

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The system enables self-service through automated genetic testing and analysis. The platform automatically processes genetic data, compares it against known markers, and generates treatment recommendations without requiring manual clinical judgment about genetic compatibility, making the system efficient and scalable

Inventive Principle:
Principle #25Self-service

2Adaptability or versatility

If genetic testing is integrated into healthcare systems, then personalized treatment recommendations can be provided, but current electronic medical record systems lack the ability to accept and display genomic information

Engineering Contradiction:
Improvepersonalized treatment capabilityVSAvoidsystem integration complexity
Core Design Contradiction:
Adaptability or versatilityVSDevice complexity

Solution Approach 1:

The system introduces an intermediary platform that bridges genetic testing laboratories and existing electronic medical record systems. This intermediary layer handles data translation, standardization, and integration, allowing genomic information to be incorporated into existing healthcare workflows without requiring complete system replacement or complex direct integration between disparate platforms

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The system creates a universal interface that can accept various formats of genetic data and translate them into standardized clinical recommendations. The platform serves multiple functions including data reception, analysis, interpretation, and output generation, making it adaptable to different healthcare systems and testing laboratories without requiring system-specific customization

Inventive Principle:
Principle #6Universality (Multi-functionality)

3Measurement precision

If comprehensive genetic analysis is performed for all patients, then treatment efficacy can be optimized, but the complexity and cost of genomic testing may be prohibitive

Engineering Contradiction:
Improvegenetic analysis accuracyVSAvoidtesting process complexity
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The system applies local quality by performing genetic analysis only for specific markers relevant to the medication being considered. Rather than sequencing entire genomes for all patients, the platform targets specific genetic variants known to affect drug metabolism and response, reducing testing complexity and cost while maintaining clinical utility for the specific treatment decision at hand

Inventive Principle:
Principle #3Local quality

Data Source

PatentUS11380424B2System and method for genetic based efficacy testing
Publication Date: 2022.07.05 XACT LABORATORIES LLC
  • US11380424B2 patent drawing
  • US11380424B2 patent drawing
  • US11380424B2 patent drawing

AI summary

System and methods for alerting a healthcare provider to prescribed treatments having reduced or no effectiveness due to genetic composition is provided. A database containing treatments known to have reduced or no efficacy in persons having particular genetic markers is queried to determine whether any treatments prescribed by, or likely to be prescribed by, a healthcare provider to the patient are known to have reduced or no efficacy in persons having the same genetic markers as the patient. An alert containing such information is displayed at a healthcare provider system.